paraquat has been researched along with saralasin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CM; Lang, YD; Tung, JN; Wang, LF | 1 |
1 other study(ies) available for paraquat and saralasin
Article | Year |
---|---|
Paraquat increases connective tissue growth factor and collagen expression via angiotensin signaling pathway in human lung fibroblasts.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blotting, Western; Collagen; Collagen Type I; Collagen Type II; Connective Tissue Growth Factor; Dose-Response Relationship, Drug; Fibroblasts; Fluorescent Antibody Technique; Herbicides; Humans; Paraquat; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Saralasin; Signal Transduction | 2010 |